# Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas

> **NCT03405025** · NA · COMPLETED · sponsor: **University College, London** · enrollment: 28 (actual)

## Conditions studied

- Primary Hyperaldosteronism
- Primary Hyperaldosteronism Due to Adrenal Adenoma

## Interventions

- **PROCEDURE:** Endoscopic ultrasound guided radiofrequency ablation
- **DEVICE:** ultrasound

## Key facts

- **NCT ID:** NCT03405025
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-21
- **Primary completion:** 2023-02-10
- **Final completion:** 2023-05-10
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-05-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03405025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03405025, "Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03405025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*